The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis
Open accessAbstract
Background People with dementia die prematurely. Identifying differences in mortality rates between different types of dementia might aid in the development of preventive interventions for the most vulnerable populations. The aim of this study was to compare the difference in mortality rates between individuals without dementia and individuals with various types of dementia. Methods For this systematic review and meta-analysis, we did a systematic search of MEDLINE, PubMed, Embase, and Cochrane Library from inception to July 11, 2020, for cross-sectional or cohort studies that assessed mortality and survival-related outcomes among people with different types of dementia compared with people without dementia. Single-arm studies without comparison groups and autopsy studies or family studies that used a selected sample were excluded. The Newcastle-Ottawa Scale was used by two authors (D-JL and C-SC) independently to measure the methodological quality of included studies, and two authors (F-CY and P-TT) independently extracted data. We assessed differences in all-cause mortality rate and survival time from dementia diagnosis between individuals without dementia, individuals with Alzheimer's disease, and individuals with non-Alzheimer's disease dementias. The secondary outcomes were age at death and survival time from disease onset. Random-effects meta-analyses were done. Effect sizes included hazard ratios (HRs) and mean differences (MDs) with 95% CIs. Potential moderators, including age-associated moderators, were identified through meta-regression and subgroup analyses. This study is registered with PROSPERO, CRD42020198786. Findings Our database search identified 11 973 records, and we included 78 eligible studies in our analyses, encompassing 63 125 individuals with dementia and 152 353 controls. Individuals with any type of dementia had a higher mortality rate than individuals without dementia (HR 5·90, 95% CI 3·53 to 9·86), and the HR for all-cause mortality was highest for Lewy body dementia (17·88, 5·87 to 54·46). After diagnosis, the mean survival time for people with Alzheimer's disease was 5·8 years (SD 2·0). Compared with people with Alzheimer's disease, a diagnosis of any non-Alzheimer's disease dementia was associated with a higher risk of all-cause mortality (HR 1·33, 1·21 to 1·46), a shorter survival time from diagnosis (MD −1·12 years, 95% CI −1·52 to −0·72), and a younger age at death (−1·76 years, −2·66 to −0·85). Survival time from disease onset was also shorter in people with non-Alzheimer's dementia, across types, compared with people with Alzheimer's disease, but the subgroup analysis revealed that this difference was only significant for vascular dementia (MD −1·27 years, −1·90 to −0·65) and dementia with Lewy bodies (MD −1·06 years, −1·68 to −0·44). The interactions between age and several survival-related outcomes were significant. 39 (50%) of the 78 included studies were rated as good quality, and large heterogeneity ( I 2 >75%) was observed for most of the study outcomes. Interpretation Alzheimer's disease is the most common type of dementia and one of the major causes of mortality worldwide. However, the findings from the current study suggest that non-Alzheimer's disease dementias were associated with higher morality rates and shorter life expectancy than Alzheimer's disease. Developing tailored treatment and rehabilitation programmes for different types of dementia is important for mental health providers, patients, and their families. Funding None.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Classifying neurocognitive disorders: the DSM-5 approach
Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.181 · Cited by 1,116
Recent global trends in the prevalence and incidence of dementia, and survival with dementia
Prince, M., Ali, G.-C., Guerchet, M., Prina, A. M., Albanese, E., & Wu, Y.-T. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0188-8 · Cited by 876
Cause of death in patients with dementia disorders
Brunnström, H. R., & Englund, E. M. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02503.x · Cited by 246
Garcia-Ptacek, S., Farahmand, B., Kåreholt, I., Religa, D., Cuadrado, M. L., & Eriksdotter, M. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131856 · Cited by 176
Research works printed but not linked: 27
- Luengo-Fernandez, 2012, UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?, Eur J Neurol, 19, 149, 10.1111/j.1468-1331.2011.03500.x · DOI
- Ostbye, 1999, Mortality in elderly Canadians with and without dementia: a 5-year follow-up, Neurology, 53, 521, 10.1212/WNL.53.3.521 · DOI
- Larson, 2004, Survival after initial diagnosis of Alzheimer disease, Ann Intern Med, 140, 501, 10.7326/0003-4819-140-7-200404060-00008 · DOI · Paper page
- Zanetti, 2009, Life expectancy in Alzheimer's disease (AD), Arch Gerontol Geriatr, 49, 237, 10.1016/j.archger.2009.09.035 · DOI · Paper page
- Koopmans, 2003, Survival to late dementia in Dutch nursing home patients, J Am Geriatr Soc, 51, 184, 10.1046/j.1532-5415.2003.51056.x · DOI
- Wolfson, 2001, A reevaluation of the duration of survival after the onset of dementia, N Engl J Med, 344, 1111, 10.1056/NEJM200104123441501 · DOI · Paper page
- Belloni-Sonzogni, 1989, Mortality of demented patients in a geriatric institution, Arch Gerontol Geriatr, 9, 193, 10.1016/0167-4943(89)90039-3 · DOI
- Hogan, 1994, Progression and outcome of patients in a Canadian dementia clinic, Can J Neurol Sci, 21, 331, 10.1017/S0317167100040919 · DOI
- Larsson, 2018, Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia, PLoS One, 13, 10.1371/journal.pone.0202044 · DOI
- Mueller, 2017, The prognosis of dementia with Lewy bodies, Lancet Neurol, 16, 390, 10.1016/S1474-4422(17)30074-1 · DOI · Paper page
- Price, 2017, Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study, BMJ Open, 7, 10.1136/bmjopen-2017-017504 · DOI
- Williams, 2006, Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease, Neurology, 67, 1935, 10.1212/01.wnl.0000247041.63081.98 · DOI · Paper page
- Faxén-Irving, 2005, Nutritional and cognitive relationships and long-term mortality in patients with various dementia disorders, Age Ageing, 34, 136, 10.1093/ageing/afi023 · DOI
- Walker, 2000, Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies, Int J Geriatr Psychiatry, 15, 267, 10.1002/(SICI)1099-1166(200003)15:3<267::AID-GPS107>3.0.CO;2-7 · DOI
- Shamseer, 2015, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation, BMJ, 350
- Tierney, 2007, Practical methods for incorporating summary time-to-event data into meta-analysis, Trials, 8, 16, 10.1186/1745-6215-8-16 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Tobias, 1999, Assessing the influence of a single study in the meta-anyalysis estimate, Stata Tech Bull, 8
- Xu, 2014, Parkinson's disease and risk of mortality: meta-analysis and systematic review, Acta Neurol Scand, 129, 71, 10.1111/ane.12201 · DOI
- de Lau, 2005, Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study, Arch Neurol, 62, 1265, 10.1001/archneur.62.8.1265 · DOI · Paper page
- Boström, 2007, Patients with Lewy body dementia use more resources than those with Alzheimer's disease, Int J Geriatr Psychiatry, 22, 713, 10.1002/gps.1738 · DOI
- Boström, 2007, Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease, Alzheimer Dis Assoc Disord, 21, 150, 10.1097/WAD.0b013e318065c4a9 · DOI · Paper page
- Fereshtehnejad, 2014, Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry, Alzheimers Res Ther, 6, 65, 10.1186/s13195-014-0065-2 · DOI
- Chamandy, 2005, Underlying cause of death in demented and non-demented elderly Canadians, Neuroepidemiology, 25, 75, 10.1159/000086287 · DOI
- Murley, 2021, Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes, J Neurol Neurosurg Psychiatry, 92, 737, 10.1136/jnnp-2020-324903 · DOI
- Lewis, 2018, A review: mealtime difficulties following frontotemporal lobar degeneration, Dement Geriatr Cogn Disord, 46, 285, 10.1159/000494210 · DOI
- Gerritsen, 2019, Survival and life-expectancy in a young-onset dementia cohort with six years of follow-up: the NeedYD-study, Int Psychogeriatr, 31, 1781, 10.1017/S1041610219000152 · DOI
Cited by
Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review
Warren, S. L., & Moustafa, A. A. (2023) · Journal of Neuroimaging · doi:10.1111/jon.13063 · Cited by 161
Watson, R., Sanson-Fisher, R., Bryant, J., & Mansfield, E. (2023) · BMC Public Health · doi:10.1186/s12889-023-15772-y · Cited by 36
Impact of Dementia on Long-Term Hip Fracture Surgery Outcomes: An Electronic Health Record Analysis
Xue, T. (., Pan, W., Tsumura, H., Wei, S., Lee, C., & McConnell, E. S. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.11.006 · Cited by 12
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
Vijverberg, E. G. B., Scharre, D. W., Woodward, M., Catalano, S., Hamby, M. E., Grundman, M., Morgan, R. E., Iaci, J., Devins, T., & Caggiano, A. O. (2026) · Journal of Alzheimer’s Disease · doi:10.1177/13872877261437145 · Cited by 2
Albus, P., Folkerts, A.-K., Kessler, J., Köhler, S., & Kalbe, E. (2026) · The journal of prevention of Alzheimer's disease · doi:10.1016/j.tjpad.2026.100517 · Cited by 1
Metadata
- Authors
- Liang, C.-S., Li, D.-J., Yang, F.-C., Tseng, P.-T., Carvalho, A. F., Stubbs, B., Thompson, T., Mueller, C., Shin, J. I., Radua, J., Stewart, R., Rajji, T. K., Tu, Y.-K., Chen, T.-Y., Yeh, T.-C., Tsai, C.-K., Yu, C.-L., Pan, C.-C., & Chu, C.-S.
- Venue
- The Lancet Healthy Longevity
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 2
- Issue
- 8
- Pages
- e479-e488
- ISSN
- 2666-7568 (ISSN-L)
- OpenAlex
- W3184238291
- Cited by
- 213
- References
- 5
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Department of Health and Social Care
- Weston Brain Institute
- National Institutes of Health
- Guy's and St Thomas' Charity
- Canada Foundation for Innovation
- Brain and Behavior Research Foundation
- King's College London
- Ontario Ministry of Health and Long-Term Care
- BrightFocus Foundation
- Canada Research Chairs
- Medical Research Council
- Ontario Ministry of Research, Innovation and Science
- National Institute for Health and Care Research
- King's College Hospital NHS Foundation Trust
- Fondation Brain Canada
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/s2666-7568(21)00140-9
- The paper
- Liang, C.-S., Li, D.-J., Yang, F.-C., Tseng, P.-T., Carvalho, A. F., Stubbs, B., Thompson, T., Mueller, C., Shin, J. I., Radua, J., Stewart, R., Rajji, T. K., Tu, Y.-K., Chen, T.-Y., Yeh, T.-C., Tsai, C.-K., Yu, C.-L., Pan, C.-C., & Chu, C.-S. (2021). Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis. The Lancet Healthy Longevity. https://doi.org/10.1016/s2666-7568(21)00140-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.